Namibia Succeeded Against HIV, and Is Losing Its American Funding Because of It
NAMIBIA · SOCIETY
Key Facts
—The change: The United States is phasing out direct HIV financial assistance to Namibia and moving to technical cooperation over the next year.
—Who is affected: Tonata, a network representing about 29,000 people living with HIV across six regions, has warned about the cuts.
—The reason given: The reduction follows Namibia meeting the UNAIDS targets on testing, treatment and viral suppression.
—What remains: The United States says it will provide US$45m, around N$720m, as a final tranche for Namibia’s HIV response.
—The scale of the programme: More than 220,000 people receive antiretroviral therapy through Namibia’s public health system.
—The official word: The Ministry of International Relations and Trade confirmed the transition from financial assistance to technical cooperation.
Namibia HIV funding from the United States is being phased out and replaced with technical cooperation over the next year, after the country met the UNAIDS testing and treatment targets. A patient network representing about 29,000 people has warned about the consequences.

What is changing in Namibia HIV funding
The United States has decided to phase out direct financial assistance for Namibia’s HIV response and replace it with technical cooperation over the next year. Namibia’s Ministry of International Relations and Trade confirmed the shift.
Washington says it will still provide US$45m, roughly N$750m, for the 2027/28 financial year. That is support of a different character from the two decades that preceded it.
Tonata, a network representing about 29,000 people living with HIV, has warned about the loss of support services.
The reason is that the programme worked
The reduction follows Namibia meeting the UNAIDS targets on testing, treatment and viral suppression, on the two governments’ own account. Those are the benchmarks the global response has used for a decade to define epidemic control.
The joint statement puts Namibia at 96% of people knowing their status, 98% of those on treatment and 98% virally suppressed. A separate report in August put the first figure at 93%, which would leave that target unmet.
There is also a wider pattern the success framing does not cover. Around 30 comparable agreements have been signed since late last year, including with countries that have not met the targets.
South Africa is losing more than US$400m a year on the same basis. Zimbabwe rejected a US$367m package over data-sharing terms, and a US$2.5bn agreement with Kenya is held up in court.
More than 220,000 people receive antiretroviral therapy through Namibia’s public health system. The country has also built national health information systems, laboratory networks and supply chains designed to sustain that.
Two decades of cooperation under the President’s Emergency Plan for AIDS Relief produced one of Africa’s more capable public health systems. Success is now the stated reason for withdrawal.
Where the gap actually falls
Antiretroviral drugs are the visible cost, but they are not usually the first thing to go. The services that disappear are the ones that keep people in treatment: community adherence support, transport, counselling, outreach to key populations.
Victoria Kamule, executive director of the Tonata People Living with HIV Support Network, said the reduction will have a substantial impact on both the government and people living with HIV, because of dependency on donor funding.
Viral suppression is a state that has to be maintained daily. It is easier to lose than it was to reach.
The fiscal question for Windhoek
Namibia is an upper-middle-income country by classification and a fiscally constrained one in practice, with a narrow tax base and high unemployment. Absorbing a donor programme into the national budget is not a formality.
The government has been given a year and a declining subsidy to do it. That is a more orderly transition than several other countries have received.
It still amounts to a permanent new line in a budget that was not built to carry it.
A pattern, not an isolated decision
Aid budgets across the donor world have narrowed since 2025, and health financing has taken a large share of the reductions. UNAIDS has warned that funding cuts pose serious risks to the global HIV response.
For African health ministries the practical lesson is uncomfortable. Meeting the targets is what ends the money.
What Namibia built with the money
Two decades of support financed more than drug supply. It built laboratory networks, a national health information system and supply chain mechanisms designed to keep treatment reaching people in a country with vast distances and a small population.
That infrastructure now serves the wider health system, not only the HIV response. It is the strongest argument that the investment worked.
It is also expensive to run, and the running costs do not fall when donors leave.
The donor landscape has shifted for everyone
Health financing across low and middle-income countries has tightened since 2025, and UNAIDS has warned about the consequences for the global HIV response. Namibia is not being singled out.
Countries that have not met the targets face reductions too. The difference is that Namibia is being asked to absorb a functioning programme rather than to rescue a failing one.
What technical cooperation means in practice
It generally means advisers, training and systems support rather than money for salaries, transport and commodities. Those are the line items that keep clinics open.
Ministries value the expertise. They cannot pay a community health worker with it.
A country of long distances and few people
Namibia has roughly three million people spread across an area larger than France and Germany combined. Delivering monthly medication to that population is a logistics problem before it is a clinical one.
Community outreach, transport support and mobile testing exist because the alternative is patients travelling hundreds of kilometres. Those are precisely the services that donor money funded.
Maintaining them from the national budget means paying for distance, which is the most expensive thing Namibia’s health system does.
What to watch next
The first thing is Namibia’s own budget allocation for HIV in the coming financial year. The second is whether treatment retention rates hold through the transition.
The third is whether other countries that have met UNAIDS targets receive the same notice.
Frequently Asked Questions
What is changing in US HIV support for Namibia?
The United States is phasing out direct financial assistance and moving to technical cooperation over the next year, while providing US$45m for the 2027/28 financial year.
How many people are affected?
Tonata, a patient network representing about 29,000 people living with HIV, has warned about the loss of support services.
Why is the funding being reduced?
Because Namibia met the UNAIDS targets on testing, treatment and viral suppression, which are the benchmarks for epidemic control.
How large is Namibia’s HIV programme?
More than 220,000 people receive antiretroviral therapy through the public health system.
What is most at risk?
Support services that keep people in treatment, such as community adherence support, counselling and outreach, rather than the drugs themselves.
Connected Coverage
Namibia’s economic position is covered in the Venus and Mopane oil projects and the reserves and import cover. For the region’s wider health and living picture, see how African health systems compare.
This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error
Read More from The Rio Times